Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Jim Cramer Urges Investors To Sell Oracle (NYSE: ORCL) And Shun Liquor Stocks, Favoring Banks, Pharma, And Semiconductors
Cramer delivered a pointed message to investors during the member Q&A segment on the July 17th episode of CNBC Mad Money Investing Club, outlining what to sell and where to rotate. His core advice was direct: dump Oracle (NYSE: ORCL), stay away…
Indian pharma sector set for steady growth in FY27 on domestic demand: Report
The Indian pharmaceutical sector is expected to maintain a healthy growth trajectory in the coming quarters, supported by sustained domestic demand, a recovery in Contract Development and Manufacturing Organization/ Active Pharmaceutical Ingredient…
Avalyn Pharma Inc. (NASDAQ:AVLN) Receives Average Rating of 'Buy' from Analysts
Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) have earned an average recommendation of 'Buy' from the five research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold…
Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why
Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) traded up 5.3% during mid-day trading on Friday. The company traded as high as $27.76 and last traded at $27.04. 63,435 shares changed hands during trading, a decline of 84% from the…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Lowered by Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a 'buy' rating to a 'hold' rating in a report issued on Saturday. Can BioMarin Stock Live Up to Wall Street's High…
Allspring Global Investments Holdings LLC Sells 104,864 Shares of BridgeBio Pharma, Inc. $BBIO
Allspring Global Investments Holdings LLC cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 10.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional…
Curaleaf Becomes First To Supply Medical Cannabis Under Spain's New Law
Curaleaf, Medical Cannabis dispensary, Logo, Forest Hills, Queens, NY. (Photo by: Lindsey Nicholson/UCG/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images Curaleaf has become the first cannabis company to provide…
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Friday. The stock traded as high as $59.31 and last traded at $59.3330, with a volume of 347128 shares trading hands. The stock had previously closed at…
Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
UroGen Pharma (URGN) has surged nearly 180% over the past year and has strong technical momentum. URGN maintains a 100% “Buy” technical opinion from Barchart. The company's revenue is projected to more than double this year and grow…
Financiere des Professionnels Fonds d investissement inc. Takes $978,000 Position in Ascendis Pharma A/S $ASND
Financiere des Professionnels Fonds d investissement inc. bought a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought…
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) saw an uptick in trading volume on Friday. Approximately 9,615 shares changed hands during mid-day trading, an increase of 38% from the previous session's volume…
Fat cat? Weight-loss drugs may be coming for your overweight pet
Two U.S. biotech companies are testing experimental GLP-1 weight-loss treatments for overweight cats. It marks one of the earliest attempts to bring the blockbuster drug class into pet medicine. Analysts say the idea of GLP-1s for animals fits into…
Review of Manish Sabharwal and Sundeep Khanna's Made in India
Some stories deserve to be told because they capture the growth of an industry and the aspirations of a nation. Made in India: The Story of Desh Bandhu Gupta, Lupin and Indian Pharma is one such story. Elegantly written and rich in detail, it…
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?
The iShares Global Healthcare ETF (IXJ 0.46%) provides broad, established exposure to global healthcare giants, while the Invesco Nasdaq Biotechnology ETF (IBBQ +0.09%) offers a lower-cost concentrated bet on biotechnology. Both funds give…
Vimian Group AB (publ) (VIMGF) Q2 2026 Earnings Call Transcript
Vimian Group AB (publ) (VIMGF) Q2 2026 Earnings Call July 17, 2026 3:00 AM EDT Alireza Tajbakhsh - Chief Executive Officer Carl Johan Boudrie - Deputy CEO, CFO & Interim Head of Specialty Pharma Kavya Deshpande - UBS Investment Bank, Research…
Receive a Daily briefing on Pharma Industry News
Get Started